The federal report, created by the Department of Homeland Security and distributed to government agencies last week, found that the U.S. already is seeing shortages of more than 200 drugs and supplies due to international shutdowns.
The report is warning that another round of shutdowns could further strain the system in a way that many U.S.-based drugmakers would be “unable to quickly offset,” according to ABC.
“Chinese factories that produce raw ingredients for common antibiotics closed for weeks as of March, and India’s lockdown extended until the end of May,” the report said, according to ABC. “France, Germany, and China have also considered reimposing lockdown measures as COVID-19 cases have begun to reemerge.”
Read the full report here.
More articles on pharmacy:
Cheap steroid in shortage after being posited as potential COVID-19 treatment
Regeneron paid patient charity millions in kickbacks, lawsuit claims
Novartis pays DOJ, SEC $347M in kickback scheme settlement
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
